Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome

被引:95
|
作者
Gray, L
Sterjovski, J
Churchill, M
Ellery, P
Nasr, N
Lewin, SR
Crowe, SM
Wesselingh, SL
Cunningham, AL
Gorry, PR
机构
[1] Macfarlane Burent Inst Med Res & Publ Hlth, Melbourne, Vic 3001, Australia
[2] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia
[3] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia
[4] Westmead Millennium Inst, Westmead, NSW, Australia
[5] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia
关键词
HIV-1; CCR5; macrophage; tropism; TAK-779; T-20; inhibition; neutralization; sensitivity;
D O I
10.1016/j.virol.2005.04.034
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The mechanisms underlying the pathogenicity of CCR5-restricted (R5) human immunodeficiency virus type-1 (HIV-1) strains are incompletely understood. Acquisition or enhancement of macrophage (M)-tropism by R5 viruses contributes to R5 HIV-1 pathogenesis. In this study, we show that M-tropic R5 viruses isolated from individuals with acquired immunodeficiency syndrome (late R5 viruses) require lower levels of CD4/CCR5 expression for entry, have decreased sensitivity to inhibition by the entry inhibitors TAK-779 and T-20, and have increased sensitivity to neutralization by the Env MAb IgG1b12 compared with non-M-tropic R5 viruses isolated from asymptomatic, immunocompetent individuals (early R5 viruses). Augmenting CCR5 expression levels on monocyte-derived macrophages via retroviral transduction led to a complete or marginal restoration of M-tropism by early R5 viruses, depending on the viral strain. Thus, reduced CD4/CCR5 dependence is a phenotype of R5 HIV-1 associated with M-tropism and late stage infection, which may affect the efficacy of HIV-1 entry inhibitors. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:384 / 398
页数:15
相关论文
共 50 条
  • [1] Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients
    Elizabeth D. A. Wheeler
    Cristian L. Achim
    Velpandi Ayyavoo
    Journal of NeuroVirology, 2006, 12 : 200 - 210
  • [2] Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients
    Wheeler, Elizabeth D. A.
    Achim, Cristian L.
    Ayyavoo, Velpandi
    JOURNAL OF NEUROVIROLOGY, 2006, 12 (03) : 200 - 210
  • [3] Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A
    Vicenti, Ilaria
    Lai, Alessia
    Giannini, Alessia
    Boccuto, Adele
    Dragoni, Filippo
    Saladini, Francesco
    Zazzi, Maurizio
    JOURNAL OF CLINICAL VIROLOGY, 2019, 111 : 12 - 18
  • [4] Enhanced CD4+cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection
    Wade, Jessica
    Sterjovski, Jasminka
    Gray, Lachlan
    Roche, Ichael
    Chiavaroli, Lisa
    Ellett, Anne
    Jakobsen, Martin R.
    Cowley, Daniel
    Pereira, Candida da Fonseca
    Saksena, Nitin
    Wang, Bin
    Purcell, Damian F. J.
    Karlsson, Ingrid
    Fenyoe, Eva-Maria
    Churchill, Melissa
    Gorry, Paul R.
    VIROLOGY, 2010, 396 (02) : 246 - 255
  • [5] The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor-recipient pair
    Edo-Matas, Diana
    Rachinger, Andrea
    Setiawan, Laurentia C.
    Boeser-Nunnink, Brigitte D.
    van 't Wout, Angelique B.
    Lemey, Philippe
    Schuitemaker, Hanneke
    VIROLOGY, 2012, 422 (01) : 70 - 80
  • [6] Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17
    Kageyama, S
    Katsumoto, T
    Taniguchi, K
    Ismail, SI
    Shimmen, T
    Sasao, F
    Gao, M
    Owatari, S
    Wakamiya, N
    Tsuchie, H
    Ueda, S
    Shiraki, K
    Kurimura, T
    ACTA VIROLOGICA, 1996, 40 (04) : 195 - 200
  • [7] Production of human immunodeficiency virus type 1 (HIV-1) pseudoviruses using linear HIV-1 envelope expression cassettes
    Beels, Dominique
    Heyndrick, Leo
    Vereecken, Katleen
    Vermoesen, Tine
    Michiels, Lieve
    Vanham, Guido
    Kestens, Luc
    JOURNAL OF VIROLOGICAL METHODS, 2008, 147 (01) : 99 - 107
  • [8] Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis
    Nukuna A.
    Gendelman H.E.
    Limoges J.
    Rasmussen J.
    Poluektova L.
    Ghorpade A.
    Persidsky Y.
    Journal of NeuroVirology, 2004, 10 (Suppl 1) : 82 - 90
  • [9] Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis
    Nukuna, A
    Gendelman, HE
    Limoges, J
    Rasmussen, J
    Poluektova, L
    Ghorpade, A
    Persidsky, Y
    JOURNAL OF NEUROVIROLOGY, 2004, 10 : 82 - 90
  • [10] Isolation of human immunodeficiency virus-type 1 (HIV-1) clones with biological and molecular properties of the primary isolate
    Mild, M
    Björndal, A
    Medstrand, P
    Fenyö, EM
    VIROLOGY, 2006, 350 (01) : 58 - 66